New Products

BETHEL, Conn. — Duracell has introduced a new battery that it said would provide more power than previous models.

The Procter & Gamble-owned brand announced the launch of Duracell Quantum, which includes a Hi-Density Core and PowerCheck per indicator. The battery is sold in a red and copper color scheme.

LAKE SUCCESS, N.Y. — The Greek Gods brand introduced this week new Honey Salted Caramel yogurt. The new flavor will be available in the company's 24 oz. family-sized yogurt lineup.

"The Honey Salted Caramel is a fitting flavor extension and great complement to the creamy texture and rich taste of our yogurt. It is sure to become a fan favorite," said Basel Nassar, chief operating officer of the Hain Refrigerated Foods Division.

 SPARTANBURG, S.C. — Emdeon has given pharmacy automation products maker QS/1 certification for electronic prescriptions of controlled substances, or EPCS, QS/1 said Thursday.

RICHMOND HILL, Ontario — A new app allows patients to communicate through audio and video with their pharmacies using a smartphone, tablet or computer.

Face to FaceRx announced the launch of its Prescriptions Mobile App, which also allows patients to send the prescriptions directly to a call center where it will be input directly into the pharmacy's system for immediate dispensing.

PHOENIX — Natural snack food brand Boulder Canyon announced this week new Baked Sweet Potato Fries, a completely natural snack that mirrors the shape, taste and texture of the side dish found in restaurants across the country.

ST. SIMONS ISLAND, Ga. — Available now nationally at Walmart and other select grocery retailers, Farm Rich announced today three new snacks to the company's portfolio.

TORONTO — Bouche Baby Inc. announced today the commercial release of its new baby-to-toddler feeding system, which includes the Take 'N Shake Feeding Bottle with Integrated Formula Compartment.

WASHINGTON — Nearly 450 drugs are under development for treating neurological disorders, according to a report by a drug industry trade group.

The Pharmaceutical Research and Manufacturers of America said in a report released Wednesday that drug makers had 444 drugs in clinical development or awaiting Food and Drug Administration approval for a range of diseases, ranging from mild to serious.